Tenders Are Invited For Pharmaceutical Products - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V In The Period From January 1St, 2025 - December 31St, 2026

Pharmaceutical Products - Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V In The Period From January 1St, 2025 - December 31St, 2026. Conclusion Of Non-Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Benazepril + Hct (Fta),Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Combination Calcium Ion + Colecalciferol In The Dosage Forms Kta And Bta In The Pack Size Of 100.,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Cetirizine In The Dosage Form Tro And Tei.,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Levetiracetam In The Dosage Form Gra.,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pamidronic Acid.,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Combination Paracetamol + Codeine In The Dosage Forms Tab And Hkp.,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Pentoxifylline.,Conclusion Of Non-Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bezafibrate In The Dosage Form Fta.